¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø Prosthetic Valve Selection in Korea : 2019-03-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø Prosthetic Valve Selection in Korea : 2019-03-09
±³À°ÀÏÀÚ : 2019-03-09
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Prosthetic Valve Selection in Korea
ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÈäºÎ¿Ü°ú  
´ã´çÀÚ : ¹ÚÁÖ¿¬
¿¬¶ôó : 02-3410-3489  
À̸ÞÀÏ : sd000.park@samsung.com      
±³À°Á¾·ù : ±âŸ      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï-20,000 / ´çÀϵî·Ï-30,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 08:00~08:05 Ãà»ç  ¿ÀÀç°Ç(»ï¼º¼­¿ïº´¿ø) 
±âŸ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 08:05~08:10 Program ¼Ò°³  ¹ÚÇ¥¿ø(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 08:10~08:25 Current AHA & ESC guide for valve ion  ±èÀº°æ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 08:25~08:40 Design & hemodynamics of prosthetic mechanical valve  ÀÓû(ºÐ´ç¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 08:40~08:55 Design & hemodynamics of prosthetic tissue valve  À¯Àç¼®(¼¼Á¾º´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 08:55~09:15 Long-term problems and mode of failure of mechanical valve  Á¤µ¿¼·(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:15~09:30 Long-term problems and mode of failure of tissue valve  ¹Ú¼ºÁö(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:30~09:45 Late outcomes of TAVI: AMC experience  ¹Ú´ö¿ì(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:45~10:05 SMC experience of TAVI  ¹ÚÅñÔ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:05~10:25 Role of rapid deployment or sutureless AVR  ±è°æȯ(¼­¿ï´ëÇк´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:25~10:40 Role of surgical AVR in TAVI era  ¹ÚÇ¥¿ø(»ï¼º¼­¿ïº´¿ø) 
È޽Ġ03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:40~11:00 Break  () 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:00~11:15 Operative or interventional indications of aortic valve disease  ¿ÀÀç°Ç(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:15~11:35 Valve ion in middle age: mechanical vs tissue valve  ÀÌ»è(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:35~11:55 Current results of repeated surgical AVR  ¼º±âÀÍ(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:55~12:10 Current status of valve-in-valve TAVR  Jien Ye(Vancouver General Hospital) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 12:10~12:20 St. Jude standard valve vs Regent  ±èÈ£Áø(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 12:20~12:30 Mechanical AVR: old vs new mechanical valve  ÀÌÈñ¹®(¼¼Á¾º´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 12:30~12:40 Tissue valve AVR: porcine vs bovine AVR  ±èÁعü(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 12:40~12:50 Carpentier-Edwards pericardial valve: Perimount vs Magna  ÀåÇü¿ì(ºÐ´ç¼­¿ï´ëº´¿ø) 
½Ä»ç 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 12:50~13:50 Lunch  () 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:50~14:05 Age criteria of tissue valve ion in MVR  ÀÌÀç¿ø(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:05~14:25 Outcomes of repeat surgical MVR  À̽ÂÇö(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:25~14:40 Current status of valve in valve MVR  Jien Ye(Vancouver General Hospital) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:40~14:50 Late clinical outcomes of tissue valve MVR: Porcine vs Bovine  ±èÁعü(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:50~15:00 Is PPM important in MVR?  È²È£¿µ(¼­¿ï´ëÇк´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:00~15:10 Late outcomes of mechanical MVR in rheumatic disease  Á¤¼ö·Ã(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:10~15:20 Metal surface area in mechanical MVR  Á¶¾çÇö(»ï¼º¼­¿ïº´¿ø) 
È޽Ġ03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:20~15:35 Break  () 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:35~15:50 Selection of prosthetic valve in TVR: mechanical vs tissue Prefer tissue valve  È²È£¿µ(¼­¿ï´ëÇк´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:50~16:10 Prefer mechanical valve  ¹ÚÇ¥¿ø(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:10~16:30 Future perspective of transcatheter procedure in TV position  Jien Ye(Vancouver General Hospital) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:30~16:50 Optimal anticoagulation after valve surgery  À庴ö(ºÐ´çÂ÷º´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:50~17:10 Prosthetic valve ion in Mayo clinic  ¿ÀÀç°Ç(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-09 »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 17:10~17:30 Prosthetic valve ion in SMC  ¹ÚÇ¥¿ø(»ï¼º¼­¿ïº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø Prosthetic Valve Selection in Korea : 2019-03-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø 11th Catholic Vascular Ultrasound Symposium & workshop 2019 : 2019-03-10
´ÙÀ½±Û 2019³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°è¿¬¼ö°­ÁÂ(3/9) : 2019-03-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 7 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 12 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 4 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 4 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 7 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 7 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 2 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 1 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 2 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 4 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 3 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 1 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 4 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 2 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 5 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷